The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards.
Making clinical audit data transparent
In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.
What information is being made available?
National Diabetes Audit data for 2016-17 is available at England and Wales, Clinical Commissioning Group (CCG), Local Health Board (LHB), English GP practice and Specialist Diabetes Service level for:
Structured Education offers
These data do not list individual patient information nor do they contain any patient identifiable data.
Using and interpreting the data
Data from the National Diabetes Audit should not be looked at in isolation when assessing standards of care.
Accessing the data
The data are being made available on the data.gov website. GP practices and CCGs/LHBs are identified by organisation code.
What does the data cover?
The audit looks at the following areas:
What period does the data cover?
This data covers the top level findings from the 2016-17 National Diabetes Audit for the period 1 January 2016 to 31 March 2017. This National Report was published on 10 November 2017.